解剖病理学の世界市場予測（～2021）：装置（組織処理システム、ミクロトーム）、消耗品（試薬、抗体）、組織病理学、細胞病理学...市場調査レポートについてご紹介

1 Introduction (Page No. – 13)
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Markets Covered
1.2.2 Years Considered for the Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders

2 Research Methodology (Page No. – 16)
2.1 Secondary Data
2.1.1 Key Data From Secondary Sources
2.2 Primary Data
2.2.1 Key Data From Primary Sources
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Market Breakdown and Data Triangulation
2.5 Assumptions for the Study

3 Executive Summary (Page No. – 23)
3.1 Introduction

4 Premium Insights (Page No. – 29)
4.1 Anatomic Pathology Market: Market Overview
4.2 Geographic Analysis: Market, By Product & Service
4.3 Anatomic Pathology Market Size, By Application, 2016 vs 2021
4.4 Anatomic Pathology Market Size, By Region, 2016–2021

5 Market Overview (Page No. – 32)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Incidence of Cancer
5.2.1.2 Rapid Growth in the Geriatric Population
5.2.1.3 Growing Healthcare Expenditure
5.2.2 Restraints
5.2.2.1 Imposition of Excise Duty By the U.S. Government
5.2.2.2 Stringent Regulations and Changing Requirements
5.2.3 Opportunities
5.2.3.1 Rapid Growth in the Emerging Markets of APAC and Latin America
5.2.3.2 Increased Demand for Personalized Medicine
5.2.4 Challenges
5.2.4.1 High Degree of Consolidation
5.2.5 Trends
5.2.5.1 Increasing Number of Reagent Rental Agreements

6 Anatomic Pathology Market, By Product & Service (Page No. – 38)
6.1 Introduction
6.2 Instruments
6.2.1 Tissue Processing Systems
6.2.2 Slide Staining Systems
6.2.3 Microtomes
6.2.4 Other Instruments
6.3 Consumables
6.3.1 Antibodies & Reagents
6.3.2 Kits
6.3.3 Probes
6.3.4 Other Consumables
6.4 Services
6.4.1 Cytopathology
6.4.2 Histopathology
6.4.3 Other Services

7 Anatomic Pathology Market, By Application (Page No. – 51)
7.1 Introduction
7.2 Diseases Diagnosis
7.3 Drug Discovery & Development
7.4 Other Applications

8 Anatomic Pathology Market, By Region (Page No. – 56)
8.1 Introduction
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.4 Asia
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Rest of Asia
8.5 Rest of the World

9 Competitive Landscape (Page No. – 90)
9.1 Overview
9.1.1 Strategic Overview
9.2 Market Share Analysis
9.3 Competitive Situation and Trends
9.3.1 Product Launches & Regulatory Approvals
9.3.2 Acquisitions
9.3.3 Agreements, Partnerships, and Collaborations
9.3.4 Expansions

10 Company Profiles (Page No. – 97)
(Overview, Products and Services, Financials, Strategy & Development)*
10.1 Introduction
10.2 F. Hoffmann-La Roche AG.
10.3 Danaher Corporation
10.4 Thermo Fisher Scientific, Inc.
10.5 Laboratory Corporation of America Holdings
10.6 Quest Diagnostics Incorporated
10.7 Agilent Technologies, Inc.
10.8 Sakura Finetechnical Co., Ltd.
10.9 Biogenex Laboratories
10.10 Bio SB
10.11 Neogenomics Laboratories, Inc.

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

11 Appendix (Page No. – 120)
11.1 Insights of Industry Experts
11.2 Discussion Guide
11.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
11.4 Introducing RT: Real-Time Market Intelligence
11.5 Available Customizations
11.6 Related Reports
11.7 Author Details